TokenPost topic

BioNTech

1 TokenPost story is tagged BioNTech. The newest appear first.

Latest BioNTech stories

• BioNTech Shares Fall 6% After BNT113 Trial Misses Key Endpoint

  The Phase 2/3 trial did not meet one of its dual primary endpoints, progression-free survival.

  Oct 13, 2026, 11:48 AM EDT · Investing